Search Results
Remaining patient-centric when treating rare diseases - PRA Health Sciences
Rare Disease Drug Development and Patient Centricity
Tools of the Trade for Patient-Centric Clinical Development
Update from the Community: Quality of Life Markers
PRA Health Sciences - Decentralized Clinical Trials
RDCA-DAP: Shortening the Timeline for Developing New Treatments for Rare Diseases
Focus on Rare Disease: Putting patients in the driver's seat
Global Genes LIVE! The Patient Centered Future
Rare Disease Day 2021 Panel Discussion on Relay of Data from registries to clinical trials by Jeeva
IndustryTalk - Rare Diseases Therapies with Scott Schliebner
Day 2: Track 2, Patient’s Role, Dave Leventhal (Pfizer) Jane Larkindale, Jeffrey Sherman,
Rare Therapies:Pharmacological Chaperones and Cell Therapies
